(-)-alpha-phellandrene decreases expression ISO FXN (Homo sapiens) 6480464 alpha phellandrene results in decreased expression of FXN mRNA CTD PMID:25075043 (-)-epigallocatechin 3-gallate multiple interactions ISO FXN (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FXN mRNA CTD PMID:22079256 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FXN mRNA CTD PMID:22206623 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FXN mRNA CTD PMID:18163543 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fxn (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FXN mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FXN gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FXN mRNA CTD PMID:21570461 2,4,6-trinitrotoluene affects expression ISO Fxn (Rattus norvegicus) 6480464 Trinitrotoluene affects the expression of FXN mRNA CTD PMID:21346803 2-palmitoylglycerol increases expression ISO FXN (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of FXN mRNA CTD PMID:37199045 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO FXN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FXN mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FXN mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO FXN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FXN mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases methylation EXP 6480464 bisphenol S results in increased methylation of FXN promoter CTD PMID:33297965 4-hydroxynon-2-enal multiple interactions ISO FXN (Homo sapiens) 6480464 4-hydroxy-2-nonenal affects the reaction [Ethanol affects the expression of FXN protein] CTD PMID:33017621 7,8-dihydro-8-oxoguanine multiple interactions EXP 6480464 [FXN gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased abundance of 8-hydroxyguanine CTD PMID:26954031 acrylamide decreases expression ISO FXN (Homo sapiens) 6480464 Acrylamide results in decreased expression of FXN mRNA CTD PMID:32763439 all-trans-retinoic acid affects response to substance EXP 6480464 FXN protein affects the susceptibility to Tretinoin CTD PMID:16120311 all-trans-retinoic acid decreases expression ISO FXN (Homo sapiens) 6480464 Tretinoin results in decreased expression of FXN mRNA CTD PMID:33167477 alpha-phellandrene decreases expression ISO FXN (Homo sapiens) 6480464 alpha phellandrene results in decreased expression of FXN mRNA CTD PMID:25075043 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of FXN mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO FXN (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to FXN mRNA] CTD PMID:32406909 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of FXN mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO FXN (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of FXN promoter CTD PMID:27901495 betamethasone increases expression ISO FXN (Homo sapiens) 6480464 Betamethasone results in increased expression of FXN mRNA CTD PMID:23418481 bisphenol A affects expression ISO Fxn (Rattus norvegicus) 6480464 bisphenol A affects the expression of FXN mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FXN mRNA CTD PMID:32156529 bisphenol A increases methylation ISO Fxn (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of FXN gene CTD PMID:28505145 bisphenol A decreases expression ISO Fxn (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of FXN mRNA CTD PMID:30816183 and PMID:32528016 bisphenol F multiple interactions ISO FXN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FXN mRNA CTD PMID:28628672 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FXN mRNA CTD PMID:24982889 camptothecin increases expression ISO FXN (Homo sapiens) 6480464 Camptothecin results in increased expression of FXN protein CTD PMID:23418481 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO FXN (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to FXN gene] CTD PMID:28238834 cisplatin increases expression ISO FXN (Homo sapiens) 6480464 Cisplatin results in increased expression of FXN mRNA and Cisplatin results in increased expression of FXN protein CTD PMID:23418481 and PMID:27392435 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of FXN mRNA CTD PMID:17585979 and PMID:23811191 cobalt dichloride decreases expression ISO FXN (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of FXN mRNA CTD PMID:19320972 cyclosporin A increases expression ISO FXN (Homo sapiens) 6480464 Cyclosporine results in increased expression of FXN mRNA CTD PMID:27989131 decabromodiphenyl ether decreases expression ISO Fxn (Rattus norvegicus) 6480464 decabromobiphenyl ether results in decreased expression of FXN mRNA CTD PMID:23640034 deferiprone increases expression ISO FXN (Homo sapiens) 6480464 deferiprone results in increased expression of FXN mRNA and deferiprone results in increased expression of FXN protein CTD PMID:23418481 dexamethasone multiple interactions ISO FXN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FXN mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FXN mRNA CTD PMID:28628672 dibutyl phthalate decreases expression ISO Fxn (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of FXN mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FXN mRNA CTD PMID:17361019 and PMID:21266533 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FXN mRNA CTD PMID:30529165 doxorubicin decreases expression ISO FXN (Homo sapiens) 6480464 Doxorubicin results in decreased expression of FXN mRNA CTD PMID:29803840 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of FXN mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of FXN protein CTD PMID:33017621 ethanol multiple interactions ISO FXN (Homo sapiens) 6480464 4-hydroxy-2-nonenal affects the reaction [Ethanol affects the expression of FXN protein] more ... CTD PMID:33017621 ethanol affects expression ISO FXN (Homo sapiens) 6480464 Ethanol affects the expression of FXN protein CTD PMID:33017621 ferrostatin-1 multiple interactions ISO FXN (Homo sapiens) 6480464 FXN protein affects the reaction [ferrostatin-1 affects the reaction [CYP2E1 protein affects the susceptibility to Ethanol]] CTD PMID:33017621 finasteride increases expression ISO Fxn (Rattus norvegicus) 6480464 Finasteride results in increased expression of FXN mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FXN mRNA CTD PMID:22206623 gentamycin decreases expression ISO Fxn (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of FXN mRNA CTD PMID:33387578 hydrogen peroxide decreases response to substance ISO FXN (Homo sapiens) 6480464 FXN protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:22016819 indometacin multiple interactions ISO FXN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FXN mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FXN mRNA CTD PMID:28628672 iron atom increases metabolic processing ISO FXN (Homo sapiens) 6480464 FXN protein results in increased metabolism of Iron CTD PMID:17101455 iron atom increases abundance ISO FXN (Homo sapiens) 6480464 FXN gene mutant form results in increased abundance of Iron CTD PMID:16120311 iron atom affects metabolic processing EXP 6480464 FXN protein affects the metabolism of Iron CTD PMID:17194590 iron atom affects binding ISO FXN (Homo sapiens) 6480464 Iron binds to FXN protein CTD PMID:16911956 iron(0) increases metabolic processing ISO FXN (Homo sapiens) 6480464 FXN protein results in increased metabolism of Iron CTD PMID:17101455 iron(0) affects binding ISO FXN (Homo sapiens) 6480464 Iron binds to FXN protein CTD PMID:16911956 iron(0) increases abundance ISO FXN (Homo sapiens) 6480464 FXN gene mutant form results in increased abundance of Iron CTD PMID:16120311 iron(0) affects metabolic processing EXP 6480464 FXN protein affects the metabolism of Iron CTD PMID:17194590 ivermectin decreases expression ISO FXN (Homo sapiens) 6480464 Ivermectin results in decreased expression of FXN protein CTD PMID:32959892 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of FXN mRNA CTD PMID:12057914 lipopolysaccharide increases response to substance EXP 6480464 FXN gene mutant form results in increased susceptibility to Lipopolysaccharides CTD PMID:26954031 lipopolysaccharide multiple interactions ISO FXN (Homo sapiens) 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of FXN mRNA CTD PMID:31059760 lipopolysaccharide multiple interactions EXP 6480464 [FXN gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased abundance of 8-hydroxyguanine more ... CTD PMID:26954031 methyl methanesulfonate decreases expression ISO FXN (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of FXN mRNA CTD PMID:23649840 molsidomine increases expression ISO FXN (Homo sapiens) 6480464 Molsidomine results in increased expression of FXN mRNA CTD PMID:23418481 N-acetyl-L-cysteine affects response to substance EXP 6480464 Acetylcysteine affects the susceptibility to FXN protein mutant form CTD PMID:16120311 N-acetyl-L-cysteine multiple interactions ISO FXN (Homo sapiens) 6480464 Acetylcysteine affects the reaction [Ethanol affects the expression of FXN protein] CTD PMID:33017621 nimesulide increases expression ISO Fxn (Rattus norvegicus) 6480464 nimesulide results in increased expression of FXN mRNA CTD PMID:24136188 nimustine increases expression ISO FXN (Homo sapiens) 6480464 Nimustine results in increased expression of FXN protein CTD PMID:23418481 oxaliplatin multiple interactions ISO Fxn (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FXN mRNA CTD PMID:25729387 oxaliplatin decreases expression ISO Fxn (Rattus norvegicus) 6480464 oxaliplatin results in decreased expression of FXN mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FXN mRNA CTD PMID:34911549 paracetamol decreases expression ISO FXN (Homo sapiens) 6480464 Acetaminophen results in decreased expression of FXN mRNA CTD PMID:25704631 and PMID:31059760 paracetamol multiple interactions ISO FXN (Homo sapiens) 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of FXN mRNA CTD PMID:31059760 pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of FXN mRNA CTD PMID:23892564 pirinixic acid multiple interactions ISO FXN (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FXN mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of FXN mRNA CTD PMID:18301758 and PMID:23811191 potassium chromate multiple interactions ISO FXN (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FXN mRNA CTD PMID:22079256 potassium chromate decreases expression ISO FXN (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of FXN mRNA CTD PMID:22079256 resveratrol increases expression ISO FXN (Homo sapiens) 6480464 resveratrol results in increased expression of FXN mRNA and resveratrol results in increased expression of FXN protein CTD PMID:23418481 retinyl acetate increases expression EXP 6480464 retinol acetate results in increased expression of FXN mRNA CTD PMID:16772331 silicon dioxide decreases expression ISO FXN (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of FXN mRNA CTD PMID:25351596 sirolimus multiple interactions ISO FXN (Homo sapiens) 6480464 Sirolimus affects the reaction [FXN protein affects the reaction [CYP2E1 protein affects the susceptibility to Ethanol]] CTD PMID:33017621 sodium arsenite increases expression ISO FXN (Homo sapiens) 6480464 sodium arsenite results in increased expression of FXN mRNA CTD PMID:17879257 sulindac increases expression ISO Fxn (Rattus norvegicus) 6480464 Sulindac results in increased expression of FXN mRNA CTD PMID:24136188 thioacetamide increases methylation ISO Fxn (Rattus norvegicus) 6480464 Thioacetamide results in increased methylation of FXN promoter CTD PMID:27914986 thioacetamide decreases expression ISO Fxn (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of FXN mRNA CTD PMID:34492290 toluene decreases expression ISO Fxn (Rattus norvegicus) 6480464 Toluene results in decreased expression of FXN mRNA CTD PMID:22967744 topotecan decreases expression ISO Fxn (Rattus norvegicus) 6480464 Topotecan results in decreased expression of FXN mRNA CTD PMID:25729387 topotecan multiple interactions ISO Fxn (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FXN mRNA CTD PMID:25729387 trichostatin A affects expression ISO FXN (Homo sapiens) 6480464 trichostatin A affects the expression of FXN mRNA CTD PMID:28542535 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of FXN mRNA CTD PMID:33045310 tungsten increases expression EXP 6480464 Tungsten results in increased expression of FXN mRNA CTD PMID:30912803 urethane decreases expression ISO FXN (Homo sapiens) 6480464 Urethane results in decreased expression of FXN mRNA CTD PMID:28818685 valproic acid increases expression ISO FXN (Homo sapiens) 6480464 Valproic Acid results in increased expression of FXN mRNA CTD PMID:23179753 valproic acid affects expression ISO FXN (Homo sapiens) 6480464 Valproic Acid affects the expression of FXN mRNA CTD PMID:25979313